Krell-Roesch, Janina http://orcid.org/0000-0003-4011-9842
Syrjanen, Jeremy A.
Bezold, Jelena
Trautwein, Sandra
Barisch-Fritz, Bettina
Kremers, Walter K.
Machulda, Mary M.
Mielke, Michelle M.
Knopman, David S.
Petersen, Ronald C.
Woll, Alexander
Vassilaki, Maria
Geda, Yonas E.
Funding for this research was provided by:
National Institute on Aging (R01 AG057708, U01 AG006786, P50 AG016574, R01 AG034676)
National Institute of Mental Health (K01 MH068351)
Robert Wood Johnson Foundation
Robert H. and Clarice Smith and Abigail Van Buren Alzheimer’s Disease Research Program
Mayo Foundation for Medical Education and Research
Edli Foundation
Arizona Alzheimer’s Consortium
Karlsruher Institut für Technologie (KIT)
Article History
Received: 22 March 2021
Accepted: 22 June 2021
First Online: 26 July 2021
Declarations
:
: W.K. Kremers receives research funding from the Department of Defense, NIH, Astra Zeneca, Biogen, and Roche. M.M. Machulda receives research funding from the NIH. M.M. Mielke served as a consultant to Eli Lilly, received unrestricted research grants from Biogen, Lundbeck, and Roche, and receives research funding from the NIA, NIH, and the Department of Defense. D.S. Knopman serves on a Data Safety Monitoring Board for the Dominantly Inherited Alzheimer Network (DIAN) study and is an investigator in clinical trials sponsored by Biogen, Lilly Pharmaceuticals, and the University of Southern California. R.C. Petersen consults for Roche Inc, Merck Inc, Genentech Inc, Eisai, Inc, Biogen Inc, and GE Healthcare and receives royalties from Oxford University Press for the publication of Mild Cognitive Impairment. M. Vassilaki received research funding from Roche, and currently receives research funding from NIH and Biogen. She has equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic, and Amgen. Y.E. Geda receives funding from the NIH and Roche and served on the Lundbeck Advisory Board. J. Krell-Roesch, J.A. Syrjanen, J. Bezold, S. Trautwein, B. Barisch-Fritz, and A. Woll declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.